Exithera Pharmaceuticals, Inc.
Records under this name other than the patents Exithera Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 5 of 5 · Back to Exithera Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,994,521 | Therapeutic Compounds and Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 12,152,014 | Therapeutic compounds and compositions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 11,691,962 | Therapeutic compounds and compositions Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,501,404 | Substituted azetidinones Formerly held Term ended Term ended May 25, 2026 · From the USPTO record | Term ended | Term ended May 25, 2026 | From the USPTO record |
| US 7,217,794 | Compounds and methods for treatment of thrombosis Lapsed on the fee record Ended May 15, 2019 · From the USPTO record | Lapsed on the fee record | Ended May 15, 2019 | From the USPTO record |